{
  "name" : "twin.sci-hub.se_6363_25b0b62b82a70f81fdb5ead38dc1f743_mohammadi2017.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Nanomaterials engineering for drug delivery: a hybridization approach",
    "authors" : [ "M. Rezaa Mohammadi", "Amirali Nojoomi", "Masoud Mozafari", "Mohammed Inayathullah", "Jayakumar Rajadas" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "This journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B\nCite this:DOI: 10.1039/c6tb03247h\nNanomaterials engineering for drug delivery: a hybridization approach\nM. Rezaa Mohammadi, a Amirali Nojoomi,b Masoud Mozafari, c Arita Dubnika, ad Mohammed Inayathullah a and Jayakumar Rajadas†*ae\nThe last twenty years have witnessed great advances in biology, medicine, and materials science, leading to\nthe development of various nanoparticle (NP)-mediated drug delivery systems. Innovation in materials\nscience has led the generation of biodegradable, biocompatible, stimuli-responsive, and targeted delivery\nsystems. However, currently available nanotherapeutic technologies are not efficient, which has culminated\nin the failure of their clinical trials. Despite huge efforts devoted to drug delivery nanotherapeutics, only a\nsmall amount of the injected material could reach the desired target. One promising strategy to enhance\nthe efficiency of NP drug delivery is to hybridize multiple materials, where each component could play\na critical role in an efficient multipurpose delivery system. This review aims to comprehensively cover\ndifferent techniques, materials, advantages, and drawbacks of various systems to develop hybrid nano-\nvesicles for drug delivery. Attention is finally given to the hybridization benefits in overcoming the biological\nbarriers for drug delivery. It is believed that the advent of modern nano-formulations for multifunctional\nhybrid carriers paves the way for future advances to achieve more efficient drug delivery systems."
    }, {
      "heading" : "1. Introduction",
      "text" : "Knowledge advancements in biology, materials science, chemistry, and medicine have led us to a new era of disease diagnosis and therapy. Drug delivery is one research area where all these sciences have to closely collaborate for efficient delivery of therapeutic agents to the diseased sites. One difficulty often associated with drug delivery is the unfavorable fate and undesired in vivo interactions of therapeutic moieties. Chemists and Materials Scientists have thus devoted their efforts to resolve this issue through incorporation of the drugs with several biologically safe materials with different sizes, shapes, chemistries, compositions and physicochemical properties. In this respect, widespread classes of materials have been designed to enhance the efficiency and deliver efficient dose of therapeutics.1–5 These materials include but are not limited to\nliposomes,1 nanoparticles (NPs),2 polymersomes,3 dendrimers,4 nanotubes,6 and hydrogels.5\nThe workhorse of drug delivery has been mostly focused on cancer therapy. To reduce the side effects and toxicity issues associated with anti-cancer drugs, nano-sized vesicles have been engineered to carry the therapeutic molecules and aid their absorbance and uptake by tumor cells. This is where nanotechnology comes into play to generate various classes of NPs for drug delivery. Despite the immense efforts on the progress of nanotechnology based delivery of therapeutic agents to cancer cells, in vivo uptake still lacks selectivity,7 and various targeting strategies such as using antibodies and cell penetrating peptides have not demonstrated promising effects.8 Indeed, reviewing the published research makes it evident that only 0.7% (median) of the administered therapeutic agents on average would be eventually delivered to the specific tumor sites,8 and the rest will be delivered to unfavorable targets (known as off-target delivery), or would be cleared from the body. Similarly, for the case of neurodegenerative diseases, drug accessibility to the central nervous system (CNS) is very limited by a tight security gateway known as the blood–brain barrier (BBB).9 These in particular have a huge negative impact on the translation of nanomaterials into medicine not only from the efficiency point of view, but also from the toxicity and potential side effect standpoints.\nIn many research and technology applications, the material component of the drug delivery system must possess more than one property including biocompatibility, biodegradability,\na Biomaterials and Advanced Drug Delivery Laboratory, Stanford University School\nof Medicine, 1050 Arastradero Road, Palo Alto, CA 94304, USA b Department of Materials Science and Engineering, University of Texas,\nArlington 76019, USA c Cellular and Molecular Research Center, Iran University of Medical Sciences,\nTehran, Iran d Riga Technical University, Faculty of Materials Science and Applied Chemistry,\nInstitute of General Chemical Engineering, Rudolfs Cimdins Riga Biomaterials\nInnovations and Development Centre, Pulka str. 3/3, Riga, LV-1007, Latvia e Division of Cardiovascular Medicine, Department of Medicine,\nStanford University School of Medicine, Stanford, CA 94305, USA\n† Stanford University, 1050 Arastradero Road, Room A148, Palo Alto, CA 94304, USA. E-mail: jayraja@stanford.edu; Fax: +1 650 721 4651; Tel: +1 650 724 6806\nReceived 19th December 2016, Accepted 25th April 2017\nDOI: 10.1039/c6tb03247h\nrsc.li/materials-b\nJournal of Materials Chemistry B\nREVIEW\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nView Article Online View Journal\nJ. Mater. Chem. B This journal is©The Royal Society of Chemistry 2017\nnon-immunogenicity, and targeting capability. However, singlecomponent materials that can meet multiple characteristics are few, if any. Therefore, intensive research has been focused to engineer novel materials through making a composite system of two, three or more components. It should be noted that ‘composite’ is mainly used for materials with size scales larger than a micron,10 whereas hybrid is more common for smaller materials. The International Union of Pure and Applied Chemistry (IUPAC) has defined hybrid materials as ‘material composed of an intimate mixture of inorganic components, organic components, or both types of components’ in a scale of less than one micrometer.11\nThis review article attempted to comprehensively review the most important hybridization strategies routinely used to create multifunctional NPs for drug delivery. In addition to emerging technologies such as image guided drug delivery (IGDD), attention was also paid to the influence of hybridization on NP toxicity. The main goal here was to take a look at the hybrid structures from the materials science point of view with an eye toward clinically relevant hybrid structures. We hope that this collection of research findings, discussing nanoscale hybridization strategies, inspires chemists, biologists, pharmacists and materials scientists to develop superior hybrid drug delivery systems for multiple applications."
    }, {
      "heading" : "2. NP hybridization techniques",
      "text" : "To be able to generate a stable hybrid nanomaterial, different components should be tied together properly. Three main methods are known for hybridizing materials on the nanoscale. (i) Covalent bonding through sharing electrons between the components, (ii) physical bonding, and (iii) interlocking and entangling of solid structures (self-assembly). For instance, covalent-bonding (chemisorption) as well as physisorption\napproaches could be applied to stabilize NPs with polymers, in which NPs are covalently or physically linked to the polymer, respectively.12,13"
    }, {
      "heading" : "2.1. Physically bonded hybrid NPs",
      "text" : "Physisorbed hybrid NPs are a class of nanomaterials, in which the bonding between the two (or more) components is basically due to physical interactions, including hydrogen bonding or electrostatic interaction. The adsorption enthalpy of physical bonds is generally between 5 and 40 kJ mol 1 (40 and 800 kJ mol 1 for chemisorption), although polarity and molecular mass can influence this range.14\nThe most important advantage of physisorption techniques over chemisorption is that chemical reactions between the generally recognized as safe (GRAS) moieties can impact Food and Drug Administration (FDA) approval,15 while physical interactions are generally known to be safe and do not lead to further FDA assessments. In addition, in physiological media, competitive exchange between proteins and polymer (shell)/NP (core) bond may culminate in fast aggregation of chemisorbed NPs.16\nOne well-known example of physisorbed hybridization of NPs by electrostatic interactions is in nucleic acid delivery. DNA or RNA binds to calcium phosphate (CaP) NPs through electrostatic interactions between Ca2+ in the CaP carrier and phosphate groups (PO4\n) in the DNA or RNA structure.17 In drug loaded physisorbed hybrid NPs, physical forces between polymer and NP determine the loading efficiency of the drug. Cheng and coworkers incorporated an amino-functionalized silicon phthalocyanine into polyethylene glycol (PEG)-coated gold NPs with hydrophobic interactions.18 They reported that the net negative charge on the gold NP surface interacts with the protonated amine to further promote and stabilize drug loading on NPs. Kim and colleagues also reported that hydrophobic drug loading on gold NPs dramatically increases when a\nM. Rezaa Mohammadi\nM. Rezaa Mohammadi is the recipient of the Stanford School of Medicine BioADD annual award. He received his Master’s degree in Materials Science and Engineering from Sharif University of Technology. His current research interests include targeted drug delivery, and stem cell therapy.\nJayakumar Rajadas\nJayakumar Rajadas is the founding director of Stanford University Biomaterials and Advanced Drug Delivery Laboratory. He has won multiple honors and awards for his contributions in science and technology, including the Young Scientist Award in Chemistry, and SPARK grants from Stanford University. His lab has been involved in transforming biophysical ideas into biomaterial and drug delivery technologies. These technologies include micro-\nencapsulation of drugs, vascular grafts, bio-implants, development of small molecule and protein-based drugs, regeneration of nerve and cardiovascular tissues, and wound healing applications. He has developed a variety of hybrid nanomaterials in drug delivery, which are now in different stages of clinical trials.\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nThis journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B\nmoiety containing amine group (tamoxifen) is present on the surface of NPs, leading to the formation of electrostatic interactions.19 Thus, physical coating is a promising method to load some hydrophobic drugs onto the surface of NPs.\nExcept for biotin–avidin, physical binding is known to be inherently weak, limiting its application for intravenous drug delivery.20 The physical interactions between the avidin and biotin complex are the strongest known non-covalent interactions (Kd = 10\n15 M, Kd = affinity). The biotin–avidin bond is insensitive to extreme conditions of pH, ionic strength, and temperature, offering a promising nanoscale hybridization platform for many biomedical applications. Besides, biotinylation, owing to its mild nature, is one of the most popular methods to conjugate different moieties to cells without compromising their viability or biological activity.21 Ma and coworkers have recently developed a multifunctional hybrid structure for simultaneous drug and gene co-delivery. Fabrication was performed based on micelles and the avidin–biotin system.22 A doxorubicin (DOX)-conjugated polyion complex (D-PIC) was prepared based on poly(L-aspartic acid) and poly(2-(2-aminoethylamino)ethyl methacrylate). Plasmid DNA (pDNA) was added to generate D-PIC–pDNA NPs with positively charged surfaces. Then, the negatively charged macromolecule avidin–biotin–PEG–L-glutamate acid co-polymer was coated onto D-PIC–pDNA NPs. Finally, using avidin–biotin chemistry, transferrin was functionalized on the surface of complexes as a targeting agent. The complex protected pDNA against nuclease degradation, minimized the interference of blood proteins, facilitated tumor cell uptake, and delivered both DOX and the gene payload. Further cellular evaluations indicated that their proposed hybrid system had increased transfection efficiency in the serum and enhanced luciferase expression in HeLa and\nHepG2 cells. This multifunctional ternary complex was an efficient carrier for the targeted release of anticancer drugs and genes.22"
    }, {
      "heading" : "2.2. Chemically conjugated hybrid NPs",
      "text" : "Sharing of electrons is a platform for different atoms to form stable molecules. Every chemical modification process requires two reactable functional groups, leading to the formation of a new covalent bond. Chemisorption techniques have been widely used to fabricate hybrid nanomaterials. Most utilized chemistries and their benefits in drug delivery systems are provided below to provide some insights into chemical hybridization.\n2.2.1. Amine reactions. Functional groups capable of coupling with amine-containing moieties are the most common groups for crosslinking purposes. Amine functional groups have been frequently introduced to possess various benefits for drug delivery purposes. For instance, the presence of amine groups in the backbone of phenyl boronic acid hydrogels enhances the formation of complexes, leading to the tuning of the release of insulin within the matrix of the hydrogel.23 The amine-coupling process can be applied to conjugate to almost all proteins and peptides. Here, we briefly introduce isothiocyanate and N-hydroxysuccinimide (NHS) ester chemistries.\nThe isothiocyanate group can be formed through the reaction of an aromatic amine with nucleophiles (donor of an electron pair) such as amines, and phenolate ions of tyrosine side chains. This chemical reaction mechanism is generally popular for generating fluorescently labeled NPs. NPs functionalized with amine groups react with available fluorescence dyes, such as fluorescein isothiocyanate, rhodamine B isothiocyanate, and the Cy5.5 NHS ester (see Fig. 1).\nOne widely used method to conjugate primary amines to carboxylic groups is by using carbodiimide compounds.\nFig. 1 Two popular amine functionalization chemistries. NPs functionalized with amine can simply react with isothiocyanate (a) or NHS ester (b).\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nJ. Mater. Chem. B This journal is©The Royal Society of Chemistry 2017\nThe most commonly used carbodiimide is 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) for aqueous conjugation and decyclohexylcarbodiimide (DCC) for non-aqueous crosslinking. The foundation of this technique is to activate the carboxyl group to directly react with primary amines, leading to the formation of an amide bond. However, when the carboxyl group gets activated with EDC, an unstable intermediate (i.e. o-acylisourea) forms, which has a high tendency for hydrolysis. To enhance the efficiency of EDC chemistry, generally sulfo-NHS is employed to create a stable (dry-stable) intermediate. This technique is widely usable for nanoscale conjugation. For instance, Li et al. synthesized lanthanide-doped NaGdF4 NPs which can be conjugated to a targeting molecule (folic acid) using EDC/NHS chemistry.24 It should be noted that in their work, NPs were first functionalized with a –NH2 group, followed by activation of folic acid in EDC/NHS solution. Clearly, this idea could be used to link NHS-modified NPs and amine bearing molecules. For instance, poly(lactic-co-glycoli acid) (PLGA) NPs could be first functionalized with NHS. Then, PLGA–NHS could be further modified with an amine-bearing molecule.25\n2.2.2. Thiol reactions. The second most common bioconjugation chemistry is perhaps the thiol reaction, in which reactive groups are able to couple with sulfhydryl-containing molecules. It generally refers to the reaction of thiol containing compounds with alkenes, or ‘‘enes’’, with a very high conversion rate.15 This chemistry is very popular among biologists because it has high reaction kinetics in biologically compatible media (e.g. water and biological buffers). Generally, thiols react with alkenes through two mechanisms: Michael type addition, and radical mediated reaction, as shown in Fig. 2. In the former, generally a base abstracts a proton from a thiol, forming a thiolate anion, which performs as a nucleophile. Then, the thiolate anion attacks the electrophilic b-carbon on the alkene to form a carbon-centered anion. This intermediate then abstracts a proton from the conjugate acid to give rise to Michael addition.15\n2.2.3. Carboxylate reactions. The carboxylate functionality demonstrates low nucleophilicity in aqueous solutions, which makes it unreactive with many nucleophilic-based bioconjugate reagents. However, carbodiimides have been successfully developed, and function as zero-length crosslinking agents. Carbodiimides activate a carboxylate group for coupling with a primary amine-containing moiety, without becoming part of the final product. For instance, Cho and coworkers used EDC chemistry to conjugate acid-capped gold NPs to daunorubicin, an anticancer drug.26\n2.2.4. Hydroxyl reactions. A hydroxyl-containing moiety usually crosslinks with a molecule containing nucleophilic sections. One versatile hydroxyl reaction in nanoengineering is of N,N0-disuccinimidyl carbonate (DSC), which contains a carbonyl group (or two NHS esters). DSC is highly reactive toward neucleophiles, and can be used in both aqueous and non-aqueous media. Hydroxyl-functionalized NPs can be activated by DSC to be conjugated with amine-containing moieties, culminating in the formation of stable bonds (urethane derivative or carbamate bond). Cai et al. coupled RGD peptide\n(GSSSGRGDSPA) to PEG-modified via a chemical reaction in the presence of DSC. They found that RGD-modified PEG-stearic acid-grafted chitosan micelles are promising drug carriers for active targeting therapy with overexpressed integrin.27\nAny of the above-mentioned chemistries have their specific characteristics. Careful attention must be paid when a functionalization reaction is being selected. For instance, the carboxyl functional moiety has been reported to possess superior bioavailability.28 Or, the dithiol bond would provide strong coordination to the NP surface and increase stability in aqueous media.29 The functional group can also affect the toxicity of the system. For instance, cationic dendrimers have been reported to be neurotoxic.30 In addition, NP functionality regulates their transport in the brain parenchyma, for example, NPs with a neutral surface penetrate into brain tissue rapidly and deeply.31 In another recent study, Zhang and colleagues reported that a polyamidoamine dendrimer with hydroxyl functionality is more effective in crossing the fetal BBB, and targeting activated microglia.31 The functionality of nanovesicles can significantly affect the encapsulated drug efficiency and release as well. In one study, dendrimers were functionalized with acetyl, glycidol hydroxyl, and succinamic acid groups, and their influence was investigated on DOX encapsulation, release kinetics, and cancer cell inhibition.32 It was reported that the weak interaction between succinamic acid and the drug leads to burst release, limiting its efficiency for in vivo administration.\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nThis journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B"
    }, {
      "heading" : "2.3. Self-assembly",
      "text" : "In general, self-assembly refers to a process through which materials spontaneously organize in thermodynamically stable domains.33 This technique is a low cost method to produce ensembles of nanomaterials in a controllable fashion. In addition, some agents are sensitive to chemical reactions, thus self-assembly is a promising method for hybridizing them. The self-assembly technique has been widely applied to manufacture hybrid nanomaterials, as it also eliminates multiple steps required for their fabrication. For instance, Wang et al. reported a one-pot formation of a three-component hybridized nanocomposite: Ag NPs coated with DOX-loaded poly-L-lysine via the self-assembly technique.34 Taking advantage of the self-assembly technique, no further step was needed to give their nanocomposite a controlled release property. At the same step of self-assembly, and through using a 3,30-dithiobis(sulfosuccinimidyl propionate) cross-linker for the poly-L-lysine shell, disassembly of poly-L-lysine was achieved through cleavage of the disulfide bond by thiol. In another study, a hybrid NP consisting of an anti-tuberculosis pro-drug, a photosensitizer, and a trojan-horse moiety was self-assembled to treat tuberculosis infection. This hybrid NP demonstrated 1000-fold enhanced activity of the pro-drug (pyrazinoic acid) against mycobacteria.35 This significant enhancement is mainly due to the hybridization assembly of components for targeting, therapy, and therapy enhancement. The NP consists of three components each of which play a specific role. (i) Cholestrol, which is a trojan horse moiety and mycobacteria take it up as a nutrition carbon source during infections and growth in culture. In other words, the trojan horse moiety is a targeting moiety, providing the NPs with active targeting potential. (ii) Pyrazinoic acid, an anti-tuberculosis drug to treat tuberculosis infection, and (iii) cobalt-metalloporphyrin, a photosensitizer agent, used as a photosensitizer agent to enhance the therapeutic effect of the drug.\nThe methods we discussed so far are generally limited to the instances where all moieties are in their final form prior to hybridization. In some special cases these hybridization methods may lack selectivity and high yields. For instance, even though hybridization of metallic NPs within liposomes has a significant importance in biomedical applications, several challenges have been found for direct metal–liposome hybridization. To address this issue, a general protocol to effectively hybridize metal NPs within liposomes has been established36 and will be discussed further in Section 5."
    }, {
      "heading" : "3. Polymer based hybrid NPs",
      "text" : ""
    }, {
      "heading" : "3.1. Stimuli responsive hybrids for targeted drug delivery",
      "text" : "Stimuli-responsive (smart) materials are known to change their properties through responding to the surrounding environmental fluctuations. A variety of stimuli such as changes in pH,37 temperature,38 light,39 and enzymes40 combined with a specifically tailored response can offer a platform to deliver drugs with a controlled rate and in a stable and biologically active form. A very informative paper has reviewed the various stimuli responsive NPs.41 Among different stimuli responsive\ndrug delivery systems, stimuli responsive hydrogels have been extensively studied due to their property of retaining a large amount of water, which contributes to their blood compatibility and helps in maintaining a certain degree of structural integrity.42 Although smart gels made by solitary stimuli-responsive polymers can undergo abrupt change in response to small changes in environmental parameters, more complexity is needed to achieve a targeted and efficient drug delivery system. In many cases, making hybrid structures through combining two or more phases or incorporation of a second phase can provide desired control over the response of a particular system. In what follows, recent advances in stimuli responsive hybrid hydrogels with regard to their specific stimuli will be reviewed.\n3.1.1. pH responsive hybrid hydrogels. Each organ maintains its own characteristic pH, which can differ from 1 to 3 for the acidic stomach lumen up to 7.0 to 8.5 for the alkaline duodenum and ileum. Moreover, in some medical conditions such as in cancer the cell environments are more acidic than normal, making pH-dependent drug release to be a potential candidate for controlled drug delivery.43 Another area where pH-responsiveness might be useful is for the delivered therapeutic to avoid endosomal sequestration and enzymatic degradation. For instance, Khaled et al. synthesized fluorescently doped silica NPs wrapped inside a tunable coating of a cationic poly(2-diethylaminoethyl methacrylate) hydrogel in one step for efficient siRNA delivery.44 They employed this strategy to obtain a hybrid NP capable of siRNA release in acidic pH, and thereby protect siRNA against endosomal sequestration and enzymatic degradation. Their developed hybrid NPs accumulated at the tumor site and silenced the CXCR4 expression in mice. There are some instances that the hybrid structure is required to maintain its characteristics in acidic pH, while degrade in physiological or basic pH. For instance, in the case of devices located in the stomach, in case the stomach-residing device breaks or migrates to the lumen, the non-degradable nature of these devices could lead to intestinal obstruction or damage. To address this issue, Zhang et al. synthesized a supramolecular gel by hybridizing poly(acryloyl 6-aminocaproic acid) with poly(methacrylic acid-co-ethyl acrylate) to be sound at the stomach pH but degradable in the intestine.45\nThe pH-responsiveness of hydrogels is often attributed to the ionic pendant groups attached to the backbone of the polymer chain. In aqueous media with an appropriate pH and ionic strength, electrostatic repulsive forces caused by the ionization of the pendant groups are responsible for the swelling or deswelling of the hydrogel.\nAn osmotic swelling force caused by the presence of anionic pendant groups makes the hydrogel to swell at a pH above the polymer pKa.\n46 Most commonly studied pH-responsive polymers include poly(acrylamide) (PAAm), poly(acrylic acid), poly(methacrylic acid) (PMAA), poly(diethylaminoethyl methacrylate) and poly(dimethylaminoethyl methacrylate).47\nFormulated NPs that exhibit pH-dependent swell/deswelling have been extensively used in organ specific drug release. Peppas et al.23 used the acrylic-based polymer PMAA NPs, which was in the collapsed state in the stomach due to the protonation of carboxyl groups. The resultant hybrid PMAA–PEG copolymer\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nJ. Mater. Chem. B This journal is©The Royal Society of Chemistry 2017\nwas able to swell 40 to 90 fold and release B90% of the loaded insulin, while only 10% was released at a pH of 1.2 in the collapsed state. NPs retain their hydrophobic and collapsed state in the stomach due to the protonation of carboxyl groups. Surface functionalized inorganic particles in a hybrid system, which undergo charge reversal, have also been used to stimulate drug release in the alkaline intestinal tract. Positively charged mesoporous silica NPs were loaded with anionic drugs in an acidic environment followed by introduction to the physiological environment. Deprotonation of silanol groups, while placed in a physiological environment, generates a partial negative surface charge on the NP surface; the created internal repulsion activates the sustained release of loaded molecules.48\nThe other approachable areas for using pH sensitive drug releasing systems are tumors. Elevated rates of glucose uptake and reduced rate of oxidative phosphorylation in rapidly growing tumors result in lactic acid accumulation. Mok et al. introduced a hybrid drug carrier by functionalizing quantum dots with pH sensitive poly(L-lysine) conjugated with biotin–PEG and citraconic anhydride.49 Cleavage of citraconylated amide linkages under acidic conditions results in surface charge reversal and NP uptake by HeLa cells.\nWu et al. prepared chitosan–PMAA nanogels with both physical and covalent crosslinking methods (both chitosan and PMAA chains are pH-sensitive).5 Reversible pH-induced volume transitions of the chitosan–PMAA nanogels modify the physicochemical environment of the embedded CdSe quantum dots for converting chemical/biochemical signals to optical signals and regulate the release of temozolomide trapped in the gels in the pH range of 5–7.4 found in tumors.\nRecently, hybrid poly-(L-histidine)-based pH responsive systems have been used for sustained drug release hybrid systems using two already discussed approaches: self-assembled NPs composed of polymeric blocks or components containing ionizable groups that undergo pH-dependent structural changes or destabilization.50 Hybrid microdevices have also been introduced using stimuli responsive nanogels. Chen et al. reported a microdevice by embedding a nanogel, as pH responsive valves, into a composite membrane, resulting in a controlled release over a pH change from 7.4 to 4.51\n3.1.2. Temperature responsive hybrid hydrogels. Other most studied stimuli responsive materials for biomedical applications are thermo-responsive polymers, which undergo change in their solubility in response to changes in temperature.52 A thermosensitive polymeric solution exhibits temperature-dependent and reversible swelling/deswelling or sol–gel transitions depending on the polymer chain structure.53 The most thermally responsive hydrogel systems are N-isopropylacrylamide (NIPAAm), poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide), PEG-biodegradable polyester copolymers, poly(organophosphazenes) and 2-(dimethylamino) ethyl methacrylate.\nThere are two main types of thermoresponsive polymers; the first presents a lower critical solution temperature (LCST) while the second presents an upper critical solution temperature (UCST). LCST and UCST are the respective critical temperature points below and above which the polymer and solvent are\ncompletely miscible. The LCST system is mostly preferred for drug delivery technologies due to the need for lower temperatures compared to UCST systems. The LCST transition is an entropically driven effect, which is also called the ‘‘hydrophobic effect’’. The most commonly used LCST thermosensitive polymer is poly(N-isopropyl acrylamide), which shows a sharp and discontinuous LCST transition at 32 1C.54 However, because of disadvantages such as non-biodegradability and cytotoxicity due to the presence of quaternary ammonium in its structure, usage of NIPAM homopolymers has been limited.52 Neradovic et al.55 introduced the concept of biodegradable NIPAAm-based systems by developing hybrid NIPAM systems containing hydrolytically or enzymatically labile bonds. While the LCST of the system is below 37 1C resulting in gel formation at body temperature, cleavage of labile groups decreases the hydrophobicity of the system and increases the LCST which makes the polymer soluble and degradable over time. A series of these hydrogels have been synthesized with the potential as cell and drug delivery platforms.56,57\nA series of hybrid hydrogels based on glycidyl methacrylated chitosan and N-isopropylacrylamide with epoxy end group have been reported,58 showing the influence of drug–polymer interactions, network porosity, and degree of hydrophilicity of the matrix on the drug release rate. Epoxy groups have been incorporated as functional groups into thermosensitive microgels, as they can be modified to become vicinal diols, amines, and aldehyde groups.58\n3.1.3. Light responsive hybrid hydrogels. Using light as a trigger to activate desired reactions at specific areas has been extensively studied in photodynamic therapy.59 The main advantages of the light-responsive systems include rapid response, minimal invasiveness and localized application onto a specific area by selective irradiation.60 Another main application of lighttriggered systems may be drug release from a photo-responsive delivery system in the target tissue achieved by either photochemical reactions or conformational changes.61 Many hybrid drug delivery systems are designed by introduction of photochromic compounds such as azobenzene, spiropyran, o-nitrobenzyl and coumarin into polymeric miscelles.62 Functional inorganic NPs have also been incorporated into the micelles by self-assembly processes to improve the loading capability and morphological stability, by a self-assembly process. This strategy could combine the beneficial properties of the inorganic NPs with polymeric micelles for better application in drug delivery.63,64 Xing et al. designed light-responsive nanocarriers based on hollow mesoporous silica NPs modified with a spiropyran-containing copolymer. The hydrophilic–hydrophobic balance of the spiropyran-containing amphiphilic copolymer shifts upon ultraviolet (UV) (365 nm) irradiation and then break away from the hydrophobic surface of the hollow mesoporous silica core, which results in un-caging and release of the pre-loaded anticancer drug.65 It should be noted that to obtain adjustable light-responsiveness, semiconductors could be hybridized as light responsive moieties. By engineering the band gap of the semiconductor, a range of light-responsiveness from near infrared (NIR) to UV can be conferred to the hybrid material.66 For instance,\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nThis journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B\nBai et al. synthesized homogeneous AgIn(S1 xSex)2, and tuned its band gap by changing the amount of dopant Se.67\nOne important drawback of visible or UV light based systems is tissue-penetration, which limits the drug release to the surface while the site specific release in deep areas is severely hampered.68 In addition, skin absorbs UV and visible light quite readily while UV and intense visible light are toxic to normal tissue. In contrast, near-infrared light (wavelength between 750 and 1000 nm) has been shown to have higher penetration while having lower risks of damage to the irradiated area.63,69\nThe embedding of near infrared-active particles as a heat dissipater into thermo-responsive polymeric hydrogels or microspheres is used to design near infrared-responsive systems.70 Karg et al. designed hybrid particles made of PNIPAM microgels with a high surface charge, coated with Au nanorods (Fig. 3). Au nanorods deliver localized heat to the polymeric microgels and induce a phase transition of the polymeric chains.71 Wei et al. used a similar structure to modulate the release of Norvancomycin by changing the near infrared irradiation intensity.72\nTo achieve active targeting ability, such light-responsive drug carriers can be modified by introduction of tumor targeting compounds.73 Therefore light irradiation would disaggregate the drug carriers to release the loaded drugs after they had gathered at the specific site (e.g. tumor site).74\nFan et al. reported a hybrid system consisting of Au NPs with caged folate molecules attached on the surface, which selectively target cancer cells upon irradiation with light (Fig. 3).75 The folic acid is masked by a photocleavable o-nitrobenzyl group through covalently binding to a- and g-carboxylate groups, which interact with the folate receptor on the cell surface.76\nIt is believed that pH-responsive drug delivery systems will have their place mostly in cancer therapy, while temperature responsive systems will be employed mostly in tissue engineering and local radiotherapy. Conventional photo-responsive systems would mostly be used in cases where the lesion is readily available from outside of the body – e.g. skin cancer, but using near infrared light with higher penetration depth and utilizing targeting compounds would make deep tissue drug delivery possible.\nVarious other stimuli (e.g. redox,77 specific ions or organic molecules,78 and electric field79) have recently been used to attain controlled and site-specific delivery of drug, which shows that there are many exciting challenges in this field.\nVarious inorganic colloidal NPs are normally dispersed in solutions, and have found different applications in biomedicine. Based on the material applications may vary: for instance, superparamagnetic behavior for targeting and imaging (iron oxide (IrO) and cobalt NPs), phosphorescence characteristic for bio-sensing (doped oxide materials),80 and optical absorbance properties (Au nanorods).72 However, naked NPs are very rarely used due to their potential toxicity, and lack of colloidal stability.81 Normally NPs are hybridized by natural or synthetic polymers to provide functionality and colloidal stability."
    }, {
      "heading" : "3.2. Polymer–protein hybrid NPs",
      "text" : "The field of protein–polymer conjugation is of utmost interest in bioengineering, as the properties of protein could be remarkably improved with attaching of polymers. Polymeric NPs offer great promise in the field of medicine with a large number of products presently in clinical trials or approved for clinical use.82 It has been shown that attaching polymers significantly enhances protein solubility, stability, pharmacokinetics\nFig. 3 Sketch of a collapsed PNIPAM microgel partly covered with polyelectrolyte-coated gold nanorods (a1). TEM images of PNIPAM microgels loaded with various amounts of gold nanorods (a2–d). Sketch of a collapsed PNIPAM microgel partly covered with polyelectrolyte-coated gold nanorods (e). Reprinted with permission from ref. 71 under creative common license. Copyright 2007, John Wiley & Sons.\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nJ. Mater. Chem. B This journal is©The Royal Society of Chemistry 2017\n(blood half-life), and biodistribution, while decreasing immunogenicity.83,84 Advances in protein–polymer hybridization have focused on developing the ability to attach the polymer to protein in a site-specific manner. Site-specific control over the location of the polymer on the protein prevents heterogeneity, without compromising neither the activity nor the structure of the protein. Grafting the polymer from the protein prevents the steric problems associated with coupling two large molecules of differing properties. It greatly simplifies purification of the new protein–polymer hybrid because the low molecular weight residual monomer can be easily removed. Protein–hydrophobic polymer conjugates are expected to have interesting functionalities due to their amphiphilic molecular structures. The Zare group reported successful hybridization of bovine serum albumin with poly(methyl methacrylate) to fabricate self-assembled NPs with an encapsulated anti-cancer drug, camptothecin. NPs were injected intravenously into mice with subcutaneous colon cancer tumors. They observed a significant decrease in the size of the tumor through delivering the drug via NPs, rather than naked drug.85\nOne widely studied platform of polymer–protein hybridization is for cancer cell targeting. This hybrid structure usually contains three components: (1) the polymeric backbone network, (2) the targeting moiety such as cell penetrating peptide, and (3) imaging conjugates to track the accumulation of NPs. For instance, PAAm NPs encapsulated with a photosynthesizer (Photofrin) and multi-modal imaging agents (IrO and near infrared Cy5.5) were functionalized with the vascular tumor homing peptide F3 via a PEG linker.86 This hybrid construct was then evaluated in vitro for its ability to produce singlet oxygen, to target the nucleolin cell surface receptor, and its photosensitivity. In vitro studies demonstrated that F3-modified NPs were taken up by cells, followed by their accumulation within tumor cell nuclei. Subsequent, loss of cell viability was obtained by NP photoactivation. Using magnetic resonance imaging (MRI), in vivo\nstudies showed that these hybrid NPs were detectable in 9L glioma-bearing animals. RGDS is another popular homing peptide that has great potential to bind to the over-expressed integrins present on the surface of some cancer cells. For instance, RGDS can be linked to acryl-PEG–NHS (through the chemistry discussed in Section 2.2.1 above), as an effective targeting molecule. The acryl-PEG–RGDS then can be photopolymerized with acryl-PEG polymer. Fig. 4 shows that fluorescein labeled-PEG nanogels modified with RGDS peptide can target the HeLa cells."
    }, {
      "heading" : "3.3. Responsive polymer conjugated biomacromolecules",
      "text" : "Providing biological characteristics for synthetic polymers was always of great interest among polymer scientists. In doing so, polymer–biomacromolecule hybrid conjugates were first introduced by Ringsdorf in 1975.87 Since then, diverse polymer– biomacromolecule hybrids have been established and implemented in a vast range of areas including bioseparations, drug/siRNA delivery, enzymatic catalytic processes, diagnostics and biosensing, cell culture processes and DNA motors. Generally, three methods are applied to generate polymer–biomacromolecule NPs. (i) The first one is the ‘grafting-to’ approach which involves the covalent or physical (non-covalent, normally hydrogen-bonding) attachment of a synthetic polymer to a biomacromolecule by reactive coupling or affinity (Fig. 5a). In this method, a pre-existing polymer containing a functional chain end-group reacts with a complementary functional group on the biomacromolecule, resulting in the coupling of the biomacromolecule and polymer. (ii) In the ‘grafting from’ method, the biomacromolecule is functionalized with an initiator moiety capable of solution polymeriziation (Fig. 5b). Polymerization is initiated from a precise site on the biomacromolecule capable of generating radicals (initiator or chain transfer agent) and initiates polymerization of n monomers. (iii) In the ‘grafting-through’ approach the biomacromolecule is primarily attached to\nFig. 4 (a) Scanning Electron Microscope and (b) Atomic Force Microscope micrographs of fluorescein labeled-PEG nanogels (scale = 200 nm). (c) Optical and (d) fluorescent channels of HeLa cells incorporated with nanogels, revealing the binding/uptake of nanogels (scale = 40 mm). (e) Schematic structure of the fluorescein labeled-PEG nanogels (e). Unpublished data of M. Rezaa Mohammadi.\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nThis journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B\nmonomers, followed by polymerization (Fig. 5c). This technique, therefore, may culminate in hybrids with manifold biological species attached along the polymer backbones.88\nLee and colleagues developed green fluorescence protein (GFP) siRNA encapsulated in a disulfide-crosslinked hyaluronic acid (HA) nanogel physically for tumor-targeted intracellular delivery of siRNA.89 Glutathione was incorporated as a controlling agent, which modulated the release of siRNA. Thanks to this hybrid structure, they were able to trigger the release of siRNA from the HA nanogels through changing the concentration of glutathione in the buffer solution. In another study PEG/DNA nanogels were assembled by using thiol-functionalized branched PEG for DNA solubilization in DMSO followed by oxidative crosslinking.90 Intact plasmid DNA was released from the nanogels in the presence of a reducing agent. These examples clearly show how combining the biological moieties with synthetic polymers provides a controllable hybrid structure for drug delivery. The main challenge in this field is to protect the biomacromolecule from reacting with highly reactive free radicals."
    }, {
      "heading" : "4. Hybrid ceramic based NPs",
      "text" : "Despite the domination of polymer based nanovesicles in biomedical research, ceramic-based NPs have recently gained more attention in the field of drug delivery. Rarely seen on metallic or polymeric NPs, ceramic NPs can be engineered to possess desirable electrical (e.g., ferroelectrical and diaelectric properties), mechanical (e.g., pizeoelectrical properties, ultrahigh hardness), magnetic (e.g., superparamagnetic) and optical (e.g., photothermal, electroluminescence) properties.91 In this section, widely used ceramicbased hybrid NPs in drug delivery will be reviewed."
    }, {
      "heading" : "4.1. Hybrid NPs based on calcium phosphates",
      "text" : "Calcium phosphate (CaP) NPs are becoming increasingly widespread delivery vehicles for therapeutic agents owing to their bioactivity, higher biocompatibility (compared to many other ceramic and inorganic NPs), chemical stability, biodegradability and being native to the body, as it is a major constituent of bones and tooth enamel.92 CaP NPs have been extensively subjected to hybridization to get favorable properties. For instance, due to the inherent mechanical strength of CaP NPs, they can be applied as a strengthening scaffold for soft NPs. Schmidt and colleagues demonstrated that CaP provides mechanical reinforcement for liposome NPs, which protects the inherently fragile liposome and its drug content while in the bloodstream.93 The pH-responsive solubility characteristic of CaPs makes them great candidates for controlled release in the tumor site, as the tumor environment has acidic pH values. Owing to pH-responsiveness, CaP NPs can also be applied for intracellular delivery of degradationsensitive agents such as proteins. As lysosomes possess acidic environments, CaP can deliver proteins to the cells, and degradation of CaP NPs promotes the endo-lysosomal escape of proteins released from NPs, and release the encapsulated agent within the lysosome of the cells.94 Recent studies have also indicated that the drug release kinetics could be further controlled by tailoring the grain size, surface area and calcium-to-phosphorus ratios of CaP NPs.92,95 More interestingly, researchers have fabricated stimuli responsive CaP NPs with an on–off triggering capability. For instance, Cai et al. showed that applying an ultrasonic external force induces shape deformation of hollow CaP NPs from spherical to elliptical shapes.96 This unique shape transformation governs the release, and release kinetics, which can be regulated by the power density, duty cycle, and application of ultrasound duration. Haedicke et al. recently showed that CaP NPs can be designed not only for therapy, but as multifunctional systems ensuring drug delivery, therapy as well as diagnostic imaging.97 Table 1 provides the most important hybridized CaP NPs for drug delivery.\nFig. 5 Primary synthesis methods of polymer bioconjugates through controlled radical polymerization. (a) Grafting to, (b) grafting from (c) and grafting through approaches.\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nJ. Mater. Chem. B This journal is©The Royal Society of Chemistry 2017"
    }, {
      "heading" : "4.2. Hybrid NPs based on calcium carbonate",
      "text" : "Calcium carbonate (CaCO3) NPs are another widely used ceramic NPs in drug delivery. Similar to their other ceramic counterparts, CaCO3 NPs have been hybridized with a variety of other biomaterials. For instance, CaCO3/DNA/DOX NPs were embedded within an alginate platform. It is reported that hybridization with alginate has enhanced the delivery efficiency of CaCO3 NPs. This enhancement was attributed to the presence of the natural polysaccharide-alginate.98 In another study, the same group showed that alginate enhances the stability and transfection efficiency of CaCO3 NPs.\n99 However, no in-depth mechanism was reported to elucidate the involvement of the enhancer of alginate. Interestingly, many other reports also focused on hybrid CaCO3 NPs for gene transfection. For instance He et al. reported\nthat CaCO3 NPs can transfer DNA into targeted cells with high transfection efficiency while effectively protecting the encapsulated DNA from degradation, and can effectively inhibit lymphangiogenesis and growth of gastric cancer in vivo.100 Hollow core CaCO3 NPs were also hybridized with a mesoporous hydroxyapatite shell. This trans-membrane delivery carrier demonstrated excellent characteristics for intracellular delivery, and controlled release of therapeutic drug through acid-assisted diffusion/dissolution controlled kinetics.101"
    }, {
      "heading" : "4.3. Hybrid NPs based on silica",
      "text" : "Silica is biocompatible and biodegradable and decays into orthosilicic acid Si(OH)4, which is naturally excreted from the body through urine. It is a GRAS material (FDA ID Code: 14808-60-7).102\nTable 1 Hybrid ceramic based NPs for drug delivery\nCeramic Hybridized structure Applications Ref.\nCalcium phosphate (CaP) CaP coated liposomes CaP provides mechanical reinforcement for liposome NPs, which protects the inherently fragile liposome and its drug content from the shears in the bloodstream 93\nCaP hybridized carboxymethyl chitosan NPs decorated with KALA peptide\nCarboxymethyl chitosan was used to prevent the precipitation of CaP NPs. The hybrid NP showed sustained release of DOX with high cancer cell inhibition 137\nGelatin–iron oxide (core)/CaP (shell) NPs CaP shell acted as a drug depot, and a controlled drug release trigger in a highly pH-dependent\n138\nHydroxyapatite NPs Hybrid hydroxyapatite and chitosan biopolymer shows inhibitory effect on cancer cell proliferation with lower effects on the healthy one. To take full advantage of the nano-hydroxyapatite properties, these NPs must be in the exterior layer of the composite 139 Hydroxyapatite [Ca10(PO4)6(OH)2] NPs with a hollow core (CaCO3) and mesoporous shell structure trans-Membrane delivery carriers for the intracellular delivery, and controlled release of therapeutic drug through acid-assisted diffusion/dissolution controlled kinetics 101 CaP hybridized with 5-FC prodrug and fused carcinoembryonic antigen promoter to a suicide gene (cytosine deaminase) System was delivered into colon cancer cells. Significant delay in tumor growth for xenograft human colon carcinoma was observed 140 CaP NPs conjugated with temoporfin, the RGDfK peptide and the fluorescent dye molecule DY682-NHS Designed NPs combine diagnostic near-infrared fluorescence imaging, tumor targeting, drug delivery and photodynamic therapy 97 Multi-shell CaP core NPs coated with siRNA, encapsulated in PLGA and coated with polyethyleneimine Delivery of specific siRNA to colonic cells 141\nCalcium carbonate (CaCO3) Luciferase reporter gene plasmid was encapsulated in CaCO3–KALA–DNA NPs\nIncorporation of KALA (a cell penetrating peptide) could enhance both gene and drug delivery efficiencies 142\nCaCO3 NPs–DNA complex Transferring DNA into targeted cells with high transfection efficiency while effectively protecting the encapsulated DNA from degradation, and effectively inhibits lymph-angiogenesis and growth of gastric cancer in vivo\n100\nCaCO3/DNA/DOX co-precipitates for co-delivery of genes and drugs Compared with the gene delivery or drug delivery, the hybrid system of gene and drug co-delivery exhibits enhanced cell inhibition rate 143 Polyacrylic acid/(CaCO3) NPs Display a significant antitumor effect (76% average inhibition rate relative to the control group) 144\nIron oxide (IrO) NPs\nPolymers (dextran, polyvinyl alcohol, poly ethylene glycol, etc.)\nEnhanced colloidal stability, higher cell viability, longer circulation half-life 81\nIrO NPs embedded within red blood cells Enhanced blood circulation time 118\nTitanium oxide (TiO)\nPEGylate TiO2 NPs, Folic acid used as ligand to target folate receptors in cancer cells and drug paclitaxel for cancer therapy\nHigher adsorption capability of NPs and sustained drug release 120\nLayered double hydroxide (LDH)\nMg2–Al–NO3 LDH nanobiohybrids with DNA Some cell lines had up to 90% transfection efficiency. Can be used in non-viral gene therapy 126 Mg2–Al–LDH–Cl NPs with anticancer drug 5-fluorouracil and Allstars Cell Death siRNA Co-delivery of siRNA and an anticancer drug with the potential to overcome the drug resistance and enhance cancer treatment 127 LDH nanosheets on the surface of mesoporous silica NPs loaded with Ru(bpy)3 2+ pH-Responsive controlled release system 129\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nThis journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B\nSi NPs are photoluminescence at room temperature, and could generate singlet oxygen under photoexcitation. They also could provide hyperthermia through infrared- and ultrasoundinductions.103\nSome unique features of Si NPs have made them to come to the forefront of inorganic-based NPs in drug delivery. These features include surface hydrophilicity, various silane chemistries for surface functionalization, low cost of production, biodegradability, and variety of synthesis methods. Si NPs can generally be classified into two groups of nonporous104 and porous NPs.105 One notable example of clinically translated silica NPs is the ‘Cornell Dot’, by the Wiesner group.106 This Investigational New Drug-Approved hybrid NP consists of a silica core, 124I label for positron emission tomography (PET), Cy 5 fluorescent probe, RGDS as a targeting moiety, and PEG. This unique formulation provides NPs with dual mode imaging modality, i.e. PET and NIR (refer to Section 6 for more details on imaging modalities for NPs) to target the melanoma106 as well as to map sentinel lymph node metastasis.107\nMesoporous silica NPs have tunable pore size, high pore volume and surface area, bio-compatibility as well as adaptable functionalization of surface, making them a promising vehicle for drug delivery.108 Various stimuli have been designed to control the release of molecules from mesoporous silica NPs, such as pH change,109 ultrasound,102 photon irradiation,110 enzyme responsive characteristics111 as well as redox processes.112"
    }, {
      "heading" : "4.4. Other ceramic based hybrid NPs",
      "text" : "IrO family NPs are perhaps one of the most widely used ceramics in the fields of targeted drug delivery,113 magnetic resonance imaging (MRI),114 enzyme and protein separation,115,116 hyperthermia,117 and photothermal therapy.118\nOne of the most recent approaches to hybridizing the IrO NPs is to take advantage of natural membranes. For instance, Ren et al. reported that IrO NPs can be camouflaged through red blood cell surface coverage. After introduction into the blood stream, IrO NPs are recognized by the immune system. The uptake mechanism of IrO NPs depends on their hydrodynamic size, surface charge, and coating density. Liver kupffer cells and macrophages of spleen are the most widely reported domains to remove NPs from the blood.81\nTitanium dioxide (TiO2) NPs are biocompatible and thus widely used in pharmaceutical and cosmetic industries.119 For targeted drug delivery, TiO2 NPs have been modified with polyethylene glycol/folic acid and further functionalized with drugs.120 Such functionalized NPs possess a higher adsorption capability as well as sustained drug release for more than 50 h. Furthermore, TiO2 NPs are used as photocatalysts to kill cancer cells.121 Hybridization of the NP surface with antibodies and proteins can direct NPs towards favorable cells as well as discriminate normal cells from cancer cells.122,123\nIn recent years a new promising platform for targeted drug delivery, layered double hydroxide (LDH), has been revealed, which is biocompatible, capable of anion exchange, chemically stable and possesses pH-dependent solubility.124 LDH NPs are used to deliver negatively charged drugs as the surface of LDH\nhas a positive charge.125 Due to this property, LDH NPs can interact with various negatively charged biomolecules. Tyner et al. developed a simple, one-step process to prepare LDH nanohybrids for non-viral gene delivery,126 and recently LDH NPs have been used for siRNA and anti-cancer drug delivery.127 LDH NP surface coating and conjugation to other inorganic and organic substances have been reported by several groups to enhance the biocompatibility of NPs.128–130\nAdditionally, bioactive glass NP is suitable for hybridization with polymers and biomimetic materials. Such NPs are studied in the field of bone tissue regeneration due to their chemical interaction with bone tissue in vivo.131 Usually bioactive glass NPs are used for further scaffold and/or implant production as bioactive glasses can be doped with various functional inorganic elements.132,133 For instance, we have introduced Ag, Mg, Sr, Co, Zn, or F into different bioactive glass structures to stimulate multiple characteristics for specific applications ranging from bone and skin tissue engineering to hydatid surgery.134–136\nA summary of different ceramic based NP structures and applications can be found in Table 1."
    }, {
      "heading" : "5. Hybrid metal based NPs",
      "text" : "Metal NPs have found their way into the biomedical field as early as 1970s, when Au NPs were employed for immunolabeling.145 Since then, they have been widely used for biomedical applications. The field of bioimaging, for example, has benefited from improvements in electronics, information technology, and especially nanotechnology.17 Metal NPs have been exploited in noninvasive bioimaging for in vivo detection of tumors, monitoring delivered therapeutics and genes, evaluating the efficacy of treatments, and biodistribution assessment.\nVarious shapes and geometries of metal NPs could be easily synthesized with controllable aspect ratios to engineer their optical properties.146 It is noteworthy that the shape of NPs greatly affects their biodistribution among different organs such as lung, spleen, kidney, and liver.147 Similar to other types of NPs, metallic NPs suffer from lack of colloidal stability, which limits researchers to take advantage of them. Generally, metallic NPs should be hybridized with polymeric shells to be useable for biomedical applications. For instance noble metal NP surfaces can be modified with biological and organic molecules and thus ensure drug delivery to cellular and intracellular targets, including transport through the BBB.148,149 To prepare hybrid metal based NPs usually methods such as covalent conjugation and physical entrapment via evaporation, coating or spray-drying are used (refer to Section 2).\nIn some cases it is desired that metal NPs undergo posthybridization. For this, the precursors required for the synthesis of NPs should be present in the hybridized package, and synthesis would be conducted during or post hybridization. For instance, synthesis of metal NPs could be conducted followed by incorporation of a metal NP precursor within the liposome. Recently Lee et al. reported a study on hybrid liposome/metal NPs and successfully demonstrated the synthesis of hybrid liposome/metal NPs via\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nJ. Mater. Chem. B This journal is©The Royal Society of Chemistry 2017\nself-crystallization of metal NPs within the liposomes.36 Fig. 6 demonstrates the steps they developed to hybridize metal precursors and liposomes, and the synthesis of metal NPs posthybridization. They further synthesized composite metallic NPs (such as Ag–Au) inside liposomes using the same method, where the composition of the bimetallic compound could be tuned by varying the concentration of precursors. Their NPs showed improved endocytosis efficiency compared to pure metal NPs.36"
    }, {
      "heading" : "5.1. Au based hybrid NPs",
      "text" : "Synthesis of Au NPs can be engineered to manufacture a variety of shapes including nanorods, nanospheres, nanoprisms, nanobelts, nanocages, and nanostars. Size and shape of Au NPs determine their chemical, optical, and electromagnetic properties. For example, spherical Au NPs have a visible red wine color, which can be altered by the average size or aggregation. Au nanorods with aspect ratio within the range of 2–3 are blue,\nwhile Au nanorods with aspect ratio of 3 are black in solution. Au NPs have applications both in diagnostic and therapeutic areas. For instance, Au NPs could inhibit VEGF-induced angiogenesis and permeability in vivo.150 Readers are referred to some notable reviews.151–154\nAu NPs lack colloidal stability without proper coating. Therefore, their hybridization with polymeric coating is a common approach. Au NPs readily react with sulfur to form thiol groups on their surface, making them ideal candidates for covalent conjugation. Mercaptocarboxylic acid is one popular moiety due to its strong affinity for S on Au NPs.155 Generally, any moiety with a thiol group can react with Au NPs. EDC/NHS chemistry, and biotin/streptavidin methods are also two methods employable for Au NP hybridization. Special attention should be paid in the case of biotinylation since it inherits NPs with a hydrophobic nature, and after a threshold concentration may lead to NP aggregation and precipitation in aqueous solution. More details\nFig. 6 Self-crystalization of various metals inside liposome post-hybridization. (A) The first step is selective encoding of a reducing agent in a liposome, and (B) self-crystallization of metal precursors into metal NPs within the liposome followed by the diffusion of the metal precursors. Schematic representations of each hybrid, as well as representative TEM images (scale bar = 50 nm) and colloid pictures have been provided at the bottom. Reprinted under creative common license from ref. 36 Copyright r 2016, Jin-Ho Lee et al.\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nThis journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B\non the hybridization methods for Au based NPs are reported elsewhere.156,157 In addition to organosulfur chemistries widely used for Au NPs, new trends have emerged in Au NP hybridization chemistries, because there is still a need for superior conjugation in the context of oxidative and thermal stability and specifically the conductivity of the ligands. N-Heterocyclic carbenes is one example, which has strong affinity to form covalent bonds with the surface of NPs, and when formed possess a higher resistance towards oxygen.157\nPhysical bonding, such as electrostatic interactions, has also been studied to hybridize Au NPs. For instance, when positively charged, Au NPs could conjugate with the phosphate ester backbone of nucleic acids158 and electron-dense domains of poly(amidoamine) dendrimers.159 Using cetyl trimethyl ammonium bromide in the synthesis, Au NPs would be capped with citrate (negatively charged), which then through their positively charged domains could immobilize antibodies on the Au surface via electrostatic and hydrophobic interactions.160 Within the context of electrostatic binding, it is generally believed that NPs endowed with cationic surfaces could electrostatically bind to the cell membrane. As an illustration, Wang et al. hypothesized that the cationic modification of Au NPs enhances their incorporation onto the cell membrane due to electrostatic attraction, leading to a higher likelihood of NP endocytosis.161\nAu NPs when incorporated within liposomes could be engineered to possess thermoresponsive properties. Yu et al. studied a dual-targeting system based on Au nanorods and thermosensitive liposomes loaded with DOX. The designed system facilitated specific tumor targeting without drug leaking in systemic circulation.162 They demonstrated that PEGylated Au nanorods could not only make nanocarriers to accumulate in tumors, but also generate heat locally under NIR illumination. One important aspect in their hybrid structure is the presence of ammonium bicarbonate inside the liposome. Through the heat generated by Au nanorods, ammonium bicarbonate generates CO2 bubbles, which assist in liposome disintegration and leakage for the loaded DOX to be released. It is of particular importance to minimize the DOX release in non-specific tissues. In other words, even though this hybrid NP exhibits biodistribution other than in the tumor, DOX would only be released in the tumor, since the NIR is focused only on the tumor area. However, still long-term systematic toxicity is a concern because most of the DOX loaded hybrid NPs reside in different organs and will be released over time."
    }, {
      "heading" : "5.2. Ag based hybrid NPs",
      "text" : "Ag NPs have found their place in biomedical technology as antimicrobial agents.163 In addition, the extraordinary behavior of Ag NPs, i.e. plasmon resonant optical scattering, made them a potential candidate for optical sensing, signal enhancement, biomarker detection, and in vivo imaging.164 In the context of nanomedicine, their toxicity is the main issue. Ag NPs have shown to be cytotoxic for macrophages as reported by Park et al.165 They reported that Ag NPs are cytotoxic and induce apoptosis for cultured RAW264.7 cells. They also demonstrated that Ag NPs decreased the intracellular glutathione level, increased TNF-a in protein and gene levels, increased nitric oxide secretion, and\nincreased gene expression of matrix metalloproteinase (MMP-3, MMP-11, and MMP-19). Interestingly, they observed that when cells were treated with AgNPs, they homed in the cytosol of the activated cells, but were not present in the dead cells. To produce more stable and chemically modifiable Ag NPs, Locatelli et al. incorporated them inside the PLGA-co-PEG–COOH shell, and further conjugated chorotoxin to target the MMP-2, which is an over-expressed receptor in glioma cells in brain cancer.166 They pursued their work to study the in vivo response of their NPs.167 Not surprisingly, the biodistribution studies showed that the major organ that Ag hybrid NPs end up are kidney and bladder, with slight tumor accumulation in the case of targeting Ag NPs.\nSpecific attention has to be paid for Ag NP application in the wake of their systemic toxicity. For instance, concerns have raised regarding the involvement of Ag NP contribution in neurodegenerative diseases, owing to their ability to produce reactive oxygen species (ROS) and oxidative stress163 (more discussion on NP based toxicity can be found in Section 7)."
    }, {
      "heading" : "5.3. Other metal based hybrid NPs",
      "text" : "Si is another trace element found in the body. Biodegradability, photoluminescence, and a variety of available chemistries for Si functionalization have made these NPs interesting for drug delivery. Osminkina et al. demonstrated that aqueous Si NPs possess stable and efficient photoluminescence and could enter into the CF2Th cells, and can be used to visualize cancer cells in vitro.168 Besides, they showed that SiNPs could act as a photosensitizer of singlet oxygen generation, capable of destroying cancer cells in photodynamic therapy.\nPorous Si NPs (not to be confused with silica NPs: refer to Section 4.3) are renal clearable, providing a safer drug delivery platform in the wake of long-term toxicity and clearance. Porous Si NPs could be degraded to Si(OH)4; however, degradation may lead them to release the payload at an undesirably fast rate and quick clearance. In vivo NIR imaging of Si NPs coated with a biopolymer confirmed their clearance into the bladder at 1 h post injection.169 Immediately after formation, the surface of Si is terminated with Si hydrides (Si–Hx, x = 1–3). Hydride chemistry allows broad control over the surface chemistry of Si by various chemical modification routes, offering ease of hybridization.105 For instance, Si–C based modifications have been conducted using thermal carbonization, where the surface hydrides are substituted with dissociating acetylene under thermal treatment.170\nCu NPs have been studied for some biomedical effects including as an alternative for antibiotic treatments.163 However, Cu NPs have induced severe toxicological effects including heavy injuries in the kidney, spleen, and liver of mice after ingestion. For more details regarding metal-based hybrid NPs readers are encouraged to check some publications.171,172"
    }, {
      "heading" : "6. Hybrid NPs in image guided drug delivery",
      "text" : "Image guided drug delivery (IGDD) is the integration of delivery platform and imaging modality. IGDD not only provides the\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nJ. Mater. Chem. B This journal is©The Royal Society of Chemistry 2017\ndelivery of therapeutics, but also affords platforms to track their spatiotemporal condition. For instance, Au nanorods hybridized with Indocyanine green have been shown to possess photodynamic and photothermal properties, and can serve as a bioimaging probe in the NIR region.173 In another example, IrO NPs were conjugated with DOX and PEG via a pH sensitive acylhydrazone linkage.174 This hybrid NP was capable of releasing DOX in an acidic environment (i.e. tumor tissue) and showed enhanced T2 magnetic resonance property. As mentioned earlier, the systemic delivery of therapeutics is far from being effective, and their systemic toxicity has raised many concerns. Therefore, targeted delivery strategies are now under investigation. However, it is not yet clear what exactly occurs to the therapeutics after in vivo administration, and current targeting strategies (such as cell penetrating peptides, antibodies, or aptamers) are far from being effective. In this context, the capability of tracking and guiding the therapeutics (such as NPs) in vivo suggests a promising strategy for efficient targeted delivery. Such tracking provides insights into validation of targeted delivery, off-target accumulation, biodistribution and quantitative in vivo characterization, and real-time image guidance. Furthermore, the FDA demands the availability of a companion diagnostic test to choose patients for targeted therapies. In most of the cases this diagnostic is an imaging agent.175,176\nClearly, hybrid NPs are the most common platforms for IGDD systems, as multiple components must be present to fulfill multiple purposes. For instance, normally nanobubbles, gold NPs, and iron oxide NPs are employed as materials for ultrasound, NIR, and MRI contrast agents at the diseased site, respectively. They often hybridized with therapeutic molecules and polymeric chains to gain therapeutic index, colloidal stability, and controlled release properties. To this end, a hybrid moiety comprising imaging modalities, targeted delivery agents, and controlled-release mechanisms should be taken into account for an ideal IGDD.\nIt should be noted that IGDD could be viewed from two perspectives. First, imaging can be employed to visualize the desired target and activate the local release of delivered hybrid NPs through exogenous energy of the imaging tool.177,178 The second is in therapeutic-diagnostic (generally referred to as theranostic) area, which includes simultaneous therapy and diagnostic. Generally, a theranostic platform inherits its properties from a hybrid moiety with both delivery and targeted diagnostic features. In this platform, first the patient’s disease and biomarkers are employed for diagnostic purposes, and then the same platform would be hybridized to possess therapeutic index.174 In what follows, we will briefly introduce some notable examples of IGDD using hybrid NPs. It should be noted that many times the imaging modality just validates the targeted delivery and plays no role in aiding the efficacy of the delivery."
    }, {
      "heading" : "6.1. Hybrid radiotherapeutic NPs",
      "text" : "Radiotherapeutic NPs for image-guided radionuclide therapies take advantage of b-emitting radionucleotides hybridized with NPs.179 From the hybridization perspective, the bond between the radionucleotide and NP must be stable over a period of\nseveral days. The photon energy of certain therapeutic radionuclides is in the ideal range for nuclear imaging, i.e. from 80 to 200 keV, which is sufficient for the emitted photons to escape the body, and low enough to be easily stopped by nuclear imaging detectors. For instance, technetium-99m is a popular diagnostic nuclear medicine imaging radionuclide with a photon energy of 140 keV. The gamma photon emitted by this therapeutic radionuclide hybridized with NPs can be used to localize and quantify the biodistribution of the NPs with single-photon emission computed tomography nuclear imaging. For instance, Wang et al. hybridized multiwalled carbon nanotubes with IrO NPs, followed by radio-labeling with technetium-99m.180 It is noteworthy that to bind IrO NPs with technetium-99m, biophosphonate was employed as a linker, which has been shown to possess long term (over a month at pH 7) and strong bonding to metallic surfaces.181 This approach could be considered as multi-modal imaging, as IrO NPs participated in T2 contrast, and technetium99m was responsible for single-photon emission computer tomography imaging. With the presence of a magnet near the tumor, the same group demonstrated that their hybrid NPs (PEG–IrO–docetaxel–indium 111) could reside in the tumor as early as 1 h post injection, while without the magnet it is 4 h.182\nOne approach in radiotherapeutic hybrid NPs is to employ radiofrequency ablation and intravenous NPs. In this strategy, radiofrequency combines with either chemotherapeutic or radiotherapeutic NPs. In the former, NPs hybridized with anticancer drug display enhanced accumulation in the target tumor. For example, radiofrequency emitting needles are normally directed to tumors through image guidance, where they induce heat-initiated tumor destruction. If chemotherapeutic NPs are injected immediately after this heat generation, they accumulate more in the tumor domain. Radiotherapeutic NPs are capable of generating a local electrical current through radiofrequency, thereby creating enough heat to destruct targeted cancer cells. These NPs are normally electrically conductive materials such as Au NPs or carbon nanotubes. However, as mentioned earlier, these nanomaterials are not biodegradable, and their accumulation in the body is the source of uncertainty regarding their long-term biosafety. Therefore, Si-based NPs are employed as a promising alternative for radio ablation. Tamarov et al. showed that Si NPs in suspensions with concentrations less than 1 mg mL 1 generate 45–50 1C under radiofrequency radiation intensities within the 1–5 W cm 2 range.103 They further studied the in vivo effect of their NPs and demonstrated the efficient treatment of Lewis lung carcinoma."
    }, {
      "heading" : "6.2. Hybrid fluorescent NPs",
      "text" : "Another imaging modality for nanotherapeutics is through employment of fluorescent moieties, where we detect photons coming from tissues. However, some fundamental issues limit the application of this platform. For instance, unfavorable photon absorption of molecules (such as water, protein, lipids, etc.), auto-fluorescence, and light scattering, which lead them to possess low peneteration depth (o1 cm).183 Some novel techniques, nevertheless, have helped in overcoming these\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nThis journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B\nlimitations such as bioluminescence, optical coherent tomography, and diffused optical tomography.\nIn comparison with tomographic imaging techniques, such as MRI and computed tomography, fluorescence imaging produces faster results at a lower cost. The second NIR window (NIR-II; 1000–1700 nm) yields deeper penetration and is superior to other fluorescent moieties for in vivo investigations due to reduced absorption, scattering, and autofluorescence by biological tissues.184 Several classes of NIR fluorophores have been established for in vivo imaging: (1) synthetic fluorophores including cyanine (Cy) synthetic fluorescence semiconductor nanocrystals, and upconverting nanomaterials based on rare-earth ions.183"
    }, {
      "heading" : "6.3. Hybrid ultrasound-triggered microbubbles",
      "text" : "Microbubbles can not only act as ultrasound contrast enhancement agents, but also improve the transport of therapeutic agents through various tunable mechanical effects (e.g., shear forces, microstreaming, shockwaves, and membrane cavitation).185 One interesting approach in IGDD is to synchronize the imaging and drug release at the desired target. Microbubbles are well-known drug carriers, where they can play the role of contrast agents. When detected in the target, ultrasound stimulation aids the drug release from microbubbles. For instance, Zhu et al. fabricated microbubbles containing paclitaxel using the film hydration technique.186 Fig. 7 illustrates their system, where imaging transistor verifies their localization in the iliac artery of a restenosis model. Then, the drug delivery transducer induces ultrasound pulses leading to drug release from microbubbles.\nRapid dissolution of air-filled microbubbles, however, impedes their effective application as IGDD agents. Therefore, the bubbles are normally stabilized with lipids or proteins to diminish the surface tension between the bubbles and blood.185 There are various techniques to hybridize microbubbles. First, therapeutic agents can be loaded on the shell of microbubbles, loaded into the internal void, or inserted into the shell matrix. In the case of lipid-shelled microbubbles, the drug can be embeded in the lipid shell and bridged with microbubbles via a biotin– avidin bridging system.187\nIGDD has gained attention in brain tumor drug delivery, as BBB inhibits most therapeutic and diagnostic agents from reaching the CNS.188 For instance, efforts have been made to target glutamate carboxypeptidase II, a prostate specific membrane antigen, which is associated with neurological and psychiatric disorders.189 To address this issue, ultrasound energy has been leveraged with the imaging tools for targeted delivery to the brain. The role of ultrasound is to open up the BBB channels, and also could act as an imaging tool. For instance, Airan et al. applied magnetic resonance guided ultrasound prior to administration of imaging agents intravenously, and demonstrated a significant signal enhancement due to the superior targeted delivery to the brain.189 Similarly, Timbie et al. showed that drug loaded-PEGylated polystyrene NPs penetrate through BBB effectively followed by ultrasound treatment of an intracranial rat model of glioma.190 In this case, a T1-weighted magnetic resonance image was used to verify the activation of microbubbles, and BBB leakiness.\nRecently, applying multiple modalities in a single imaging session has gained significant attention, owing to the fact that\nFig. 7 Imaging guided drug delivery (IGDD), using microbubbles. (a) Microbubble hybrid, which contains the drug paclitaxel. (b) Schematic representation of the IGDD system, where followed by administration of microbubbles, an imaging transistor detects their localization in the iliac artery of a restenosis model. Then, the drug delivery transducer induces ultrasound pulses leading to drug release. (c) Ultrasound images of spatiotemporal localization of microbubbles up to 10 s post-administration. Reprinted under creative common license from ref. 186 Copyright r 2016, Xu Zhu et al.\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nJ. Mater. Chem. B This journal is©The Royal Society of Chemistry 2017\nmodalities with high resolution have relatively poor sensitivity, while modalities with high sensitivity have relatively poor resolution.191"
    }, {
      "heading" : "7. Toxicity and immunogenicity effect of NPs",
      "text" : "Distinct physicochemical properties of materials on the nanoscale increase the probability of their interaction with biological tissues. Three main factors are generally known to be responsible for the reported toxicity of NPs: small size, large surface area-to-volume ratio, and the ability to generate ROS.192,193 Fig. 8 schematically illustrates ROS based cytotoxicity mechanism.\nNPs possess high surface area-to-volume ratio, increasing the likelihood of surface related reactions at nano–bio interfaces. For instance, an increase in the number of electron donor or acceptor active sites at the surface of NPs leads to the formation of oxygen superoxide radicals which ultimately generate ROS.194 The generated free radicals can potentially overwhelm the natural antioxidant defenses and cause toxicity. Low doses of oxidative stress would cause a depletion in the antioxidant response element, which increases disease susceptibility.195 At high doses, pro-inflammatory signaling cascades can initiate inflammatory responses.196,197 A further increase in the oxidative stress may lead to mitochondrial perturbation and the release of pro-apoptotic factors.198 On the other hand, oxidative stress can disturb Th1/Th2 imbalance in dendritic cells, triggering an immune response.199\nAside from oxidative stress, surface reactions may have other effects, such as protein denaturation, membrane damage, DNA damage,200 non-ROS based immune reactivity,201,202 and the formation of foreign body granulomas.203 Many groups have reported persistence of NPs within cells after internalization. This sequestration of NPs could elicit inflammatory responses, cell-cycle irregularities, and gene-expression alterations.204–208\nAlthough the function of NPs mostly depends on their core structure, their bioactivity is mostly defined by the NP surface. For instance, using quantum dots and multi-walled nanotubes in biological medium requires adding hydrophilic functional groups to increase the solubility. However, in some cases the cell viability is decreased by adding hydrophilic groups, since the functional groups themselves are toxic.209,210 Moreover, NPs with surface charge show lower biocompatibility compared with the ones with a neutral surface.211 In particular, cationic NPs show higher toxicity due to their affinity to the negatively charged cell membrane.212,213\nNPs can potentially contribute to blocking ion channels or disturb their functions, which might lead to life-threatening problems. For instance, hERG ion channel – a voltage gated potassium channel that mediates the rapid delayed rectifier K+ current in the heart (IKr) – is the most susceptible channel to NP blocking. Together with other ion channels hERG determines the cardiac action potential and regulates the heartbeat.214,215 Depending on the ligand chemistry, many o2 nm NPs may become cytotoxic by disturbing the hERG channel function.216,217\nIt is believed that phagocytic cells in the reticuloendothelial system are responsible for clearing or isolating NPs. However, self-protein interactions can alter their antigenicity, provoking immune responses. In fact, these NPs can activate the complementary system by entering the systemic circulation. However, NP immunostimulation can improve antigenicity of conjugated weak antigens and thus serve as adjuvants.218 Aside from ROS activated immune response, inflammation-based immune response can cause serious hurdles associated with using NPs. It has been suggested that some NPs can activate the NF-kB pathway which is a crucial regulator of inflammation.219 For instance, based on the inherent characteristic of Au NPs to bind to a thiol group, polyacrylic acid coated Au NPs can initiate a series of conformational changes in fibrinogen which leads to\nFig. 8 NP effects as the basis for cell pathophysiology and toxicity, where reactive oxygen species (ROS) and free radicals are induced by NPs. Ion channel blockade, protein denaturation, and membrane damage are examples of NP-based toxicity (not shown in this figure). ROS is one of the primary mechanisms of NP toxicity, which may cause oxidative stress, inflammation, and consequent damage to membranes, proteins, RNA, and DNA.\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nThis journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B\nthe translocation of NF-kB to the nucleus and its subsequent activation.220"
    }, {
      "heading" : "7.1. Hybridization effect on the cytotoxicity of NPs",
      "text" : "Hybrid NPs are formed by the addition of different components working in-line to achieve desired functions. In many cases hybridization is used to increase the biocompatibility by shielding the toxic mechanisms. Surface coating, as the most popular hybridization method, prevents the surface of NPs from involving in ROS forming reactions. Also, it has been shown that the surface coating can effectively change the cellular uptake and transport properties of NPs.221,222 Although using peptides, lecithin, and polysorbate has been shown to increase the cell uptake, PEG has been reported to interfere with the NP cell uptake by suppressing any non-specific protein adsorption.223,224 This effect which is called the ‘stealth effect’ associates with the surface steric repulsion due to the high hydrophilic properties of the polyether backbone.225 Recently, Schöttler et al. showed that polystyrene nanocarriers that have been modified with PEG or poly(ethyl ethylene phosphate) and exposed to plasma proteins exhibit a low cellular uptake.226 They showed that exposed nanocarriers form a protein corona that contains an abundance of clusterin proteins (also known as apolipoprotein J). When the polymer-modified nanocarriers were incubated with clusterin, non-specific cellular uptake reduced. Hybridization has also been used to decrease the cytotoxicity of the drugs intended to be carried by NPs. Tang et al. used silica nano-rattles coated with a Au nano-shell as a chemotherapeutic agent carrier of cumulative docetaxel. Although docetaxel has been reported to have a hyperthermia-enhanced cytotoxicity,227 hematology analysis and blood biochemical assay showed that the hybrid NPs reduced systemic toxicity.228\nSotiriou et al.229 synthesized a nano-thin SiO2 shell around Janus-like Ag/Fe2O3 NPs to minimize the release of toxic Ag + ions from the nano-Ag surface, which significantly reduces the cytotoxicity while enhancing the stability during bioimaging. Metal doping has also been used to alleviate toxicological responses at the cellular level. Fe-doped ZnO NPs exhibited a reduced rate of toxicity by decreasing the inhibitory effect of Zn on embryo hatching. Furthermore, doped ZnO NPs showed reduction in pulmonary inflammation and oxidative stress response.230\nNanotechnology has provided us with the freedom to change certain properties of materials by simply reducing their size to the nanoscale. Properties such as diffusivity, blood circulation half-life, drug release, and immunogenicity can be altered to make a material a tool for imaging, sensing and therapeutic applications. However, these physicochemical property changes are not always toward enhancing the bio-compatibility. For instance, reduction in the size of a particle increases the possibility of cell uptake and unwanted surface reactions. On the other hand, in the past couple of years many of NP-based therapeutic and diagnostic agents have been used and commercialized in pharmaceuticals, medical devices and targeted molecular therapeutics and diagnostics while being used for the treatment of many types of diseases.231 As the clinical\napplications of the NPs increase, the need for improving the toxicology and immunology responses of NPs increases. Hybridization proved to be effective in shielding the toxic reactions and mechanisms. Surface coating, polymer conjugation, metal doping and making particle cored dendrimers232 are all amongst many proven hybridization techniques which improve the cytotoxicity properties of the NP based systems.\nOne important fact is that the stability of the coating is a critical issue to fully understand the acute and chronic toxicity of NPs. Therefore, the presence of the coating agent around the NPs should be taken into account, and dual-mode imaging, or different fluorescent tagged strategies are recommended to characterize the presence of coating around NPs after in vivo administration."
    }, {
      "heading" : "8. NP hybridization to overcome biological barriers",
      "text" : "Efficient accumulation of nano-therapeutics at diseased sites is greatly impeded by biological barriers. Targeted delivery of therapeutics will remain unachievable unless NPs are engineered with consideration of the biological barriers. Many research efforts have been devoted to hybridizing multiple functionalities and moieties within the overall NP design to circumvent these barriers.233 By addressing these barriers, novel hybrid design features can be rationally added to create a new generation of nanotherapeutics.147 It is noteworthy that imaging is of critical importance to study the biological barrier and biodistribution of NPs. In biological imaging, NIR has gained more attention due to its more tissue penetration and less phototoxicity (for more details refer to Section 6). It has been shown that a multilayer hybrid NP can act as a high performance computed tomography and NIR contrast agent with longer blood half life for in vivo angiography and bimodal image-guided lymph node mapping.234\nThe main difficulty that limits the site-specific delivery of nanotherapeutics is their nonspecific and unfavorable uptake by healthy organs. Immediately after being injected, the mononuclear phagocyte system (MPS) sequesters NPs and clears them from circulation. The MPS consists of phagocytic cells, which are mostly resident macrophages in the spleen.147 Followed by incorporation of NPs into the biological media, proteins get adsorbed onto the surface of NPs, forming a protein corona. This corona leads NPs to attach to specific receptors on the surface of phagocytes, and go through phagocytosis.235\nFig. 9(a) demonstrates in vivo biological barriers to entrap administered NPs. First, opsonins create a protein corona around the NPs, leading them to be recognizable by resident macrophages. This leads the NPs to accumulate in off-target areas such as spleen and liver, which is one source of NP-based toxicity. The next level of barrier arises from hemorheological limitations, originating from the shape of the NPs. Spherical NPs tend to travel far from the vascular endothelial cells, thus limiting the efficiency of NPs for both active and passive targeting. Leaky vasculature and fast tumor cell growth culminates in intra-tumoral pressure, counteracting against the localization\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nJ. Mater. Chem. B This journal is©The Royal Society of Chemistry 2017\nof NPs from endothelium to tumor domain. This phenomenon is known as interstitial fluid pressure. Endosomes possess an acidic environment (with the pH range between 4.5 and 6.5), and may severely affect the therapeutic cargos, especially in the case of genetic materials. Finally, even when the drug accumulates in the tumor cells, drug efflux pumps expel the drugs out of the cell.147 Fig. 9(b) shows methods to circumvent the nonspecific uptake of NPs through engineering the surface of NPs. Followed by incorporation of NPs into the biological media, proteins form a corona around them. This leads NPs to attach to specific receptors on the surface of phagocytes, and go through phagocytosis. PEG limits the corona formation around NPs through forming a hydration layer and conformational cloud. Another approach is hybridizing NPs with CD47 protein to limit NP recognition by MPS for phagocytosis.236 Finally, ‘camouflage’ of NPs with biomimetic coatings such as cell membranes extracted from autologous leukocytes237 and red blood cells238 provides a longer blood half-life. For instance, hybridizing the surface of NPs with PEG is a classical strategy to overcome the short blood circulation. PEG has highly flexible hydrocarbon chains, with a large number of plausible conformations. This behavior leads to the formation of a conformational ‘‘cloud’’ around the NPs.239 PEG also consists of an oxygen atom (ether group) in every repeating unit of the polymer, which creates tight conjunction with the surrounding water molecules, thus forming a hydration layer around NPs, which makes them ‘invisible’ for the MPS system. Indeed, water molecules can readily adsorb onto the NPs with hydrophilic surfaces, leading to NPs with enhanced blood half-lives.240 Although PEG has been used in several clinical products, the recent anti-PEG\nFig. 9 Nanoparticle (NP) hybridization to overcome in vivo barriers. (a) Sequential biological and physical barriers for NPs upon intravenous administration. First, opsonins create a protein corona around the NPs, leading them to be recognizable by resident macrophages. This leads the NPs to accumulate in off-target areas such as spleen and liver, which also creates toxicity. Hemorheological limitations diminish the NP absorption by endothelial cells. Leaky vasculature and fast tumor cell growth culminates in intra-tumoral pressure, counteracting against the passage of NPs from endothelium to the tumor domain. Endosomes possess an acidic environment, and may severely affect the therapeutic cargos. Finally, drug efflux pumps expel the drugs out of the cell. (b) Hybridization approaches for mononuclear phagocyte system (MPS) avoidance and prolonged circulation. PEG limits the corona formation around NPs through forming a hydration layer and conformational cloud. Another approach is hybridizing NPs with CD47 to limit the NP recognition by MPS for phagocytosis. Finally, a ‘camouflage’ of NPs with biomimetic coatings such as cell membranes extracted from autologous leukocytes and red blood cells provides a longer blood half-life. Reprinted with permission from ref. 147 Copyright 2015, Nature Publishing Group.\nPu bl\nis he\nd on\n2 3\nM ay\n2 01\n7. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 24\n/0 5/\n20 17\n1 4:\n41 :3\n0.\nThis journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B\nimmunological responses have led researchers to find other stealth coating alternatives.239"
    }, {
      "heading" : "9. Conclusion and future perspective",
      "text" : "Early generations of NPs found their ways in nanomedicine, as limitations and harmful off-target effects of drugs became apparent. Rapid, unfavorable, and unselective tissue distribution as well as toxicity and side effects led researchers to develop nanovesiclemediated drug delivery. Even though these improvements were found to be beneficial in terms of reducing drug-related morbidity, the currently available NP formulations for targeted drug delivery have not culminated in favorable clinical outcomes, owing to lack of specificity and biological incompatibility. Multifunctional all-in-one NPs are promising candidates for targeted drug delivery and controlled release, as a single hybridized component can be engineered to possess more than one desired property. Through the hybridization strategy, researchers are starting to develop hybrid nanomaterials to overcome the challenges in the pathway of NP clinical translation.\nAmong various hybridized NPs, biomimetic NP hybridization seems to offer a promising perspective for the future direction of NP-mediated targeted drug delivery. Improved knowledge of biological barriers facing NPs, and their evolution in different diseases, together with innovations in materials science, will result in efficacious and target-specific drug delivery.\nAbbreviations\nNPs Nanoparticles CNS Central nervous system BBB Blood–brain barrier IUPAC International union of pure and applied chemistry GRAS Generally recognized as safe FDA Food and Drug Administration CaP Calcium phosphate PEG Polyethylene glycol DOX Doxorubicin D-PIC Doxorubicin-conjugated polyion complex pDNA Plasmid DNA NHS N-Hydroxysuccinimide DSC N,N0-Disuccinimidyl carbonate PAAm Poly(acrylamide) PMAA Poly(methacrylic acid) NIPAAm N-Isopropylacrylamide LCST Lower critical solution temperature UCST Upper critical solution temperature UV Ultraviolet NIR Near infrared IrO Iron oxide PET Positron emission tomography LDH Layered double hydroxide Cy Cyanine MPS Mononuclear phagocyte system\nCompeting financial interest\nThe authors declare no competing financial interest."
    }, {
      "heading" : "Acknowledgements",
      "text" : "M. Rezaa Mohammadi acknowledges Ahmad G Soltan Abadi for his kind support. A. D. is grateful to the Baltic-American Freedom Foundation for supporting this work."
    } ],
    "references" : [ {
      "title" : "Fundamentals and applications of nanomaterials",
      "author" : [ "Z. Guo", "L. Tan" ],
      "venue" : "Artech house, MA, USA,",
      "citeRegEx" : "Guo and Tan,? \\Q2009\\E",
      "shortCiteRegEx" : "Guo and Tan",
      "year" : 2009
    } ],
    "referenceMentions" : [ ],
    "year" : 2017,
    "abstractText" : "The last twenty years have witnessed great advances in biology, medicine, and materials science, leading to the development of various nanoparticle (NP)-mediated drug delivery systems. Innovation in materials science has led the generation of biodegradable, biocompatible, stimuli-responsive, and targeted delivery systems. However, currently available nanotherapeutic technologies are not efficient, which has culminated in the failure of their clinical trials. Despite huge efforts devoted to drug delivery nanotherapeutics, only a small amount of the injected material could reach the desired target. One promising strategy to enhance the efficiency of NP drug delivery is to hybridize multiple materials, where each component could play a critical role in an efficient multipurpose delivery system. This review aims to comprehensively cover different techniques, materials, advantages, and drawbacks of various systems to develop hybrid nanovesicles for drug delivery. Attention is finally given to the hybridization benefits in overcoming the biological barriers for drug delivery. It is believed that the advent of modern nano-formulations for multifunctional hybrid carriers paves the way for future advances to achieve more efficient drug delivery systems.",
    "creator" : null
  }
}